Effects of thromboxane synthetase inhibitor (OKY-046) on urinary prostaglandin excretion and renal function in streptozotocin-induced diabetic rat
- 30 June 1994
- journal article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 8 (2) , 126-132
- https://doi.org/10.1016/1056-8727(94)90062-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Reduction of urinary albumin excretion by thromboxane synthetase inhibitor, OKY-046, through modulating renal prostaglandins in patients with diabetic nephropathyDiabetes Research and Clinical Practice, 1990
- Glomerular size and charge selectivity in insulin-dependent diabetes mellitusKidney International, 1988
- Sex and age-related differences in the urinary excretion of TXB2 in normal human subjects: A possible pathophysiological role of TXA2 in the aged kidneyProstaglandins, Leukotrienes and Medicine, 1984
- In vitro prostaglandin synthesis by human glomeruli and papillaeProstaglandins, 1982
- The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathiesThe American Journal of Medicine, 1982
- Thromboxane A2 is the major arachidonic acid metabolite of human cortical hydronephrotic tissueProstaglandins, 1981
- Radioimmunoassay of Prostaglandins Fα, E1 and E2 in Human PlasmaEuropean Journal of Clinical Investigation, 1975
- Prostaglandin endoperoxides VII. Novel transformations of arachidonic acid in guinea pig lungBiochemical and Biophysical Research Communications, 1974
- Radioimmunoassay Measurement of Prostaglandins E, A, and F in Human PlasmaJournal of Clinical Investigation, 1973
- ON THE COLORIMETRIC DETERMINATION OF CREATININE BY THE JAFFE REACTIONJournal of Biological Chemistry, 1945